Business Context and Reporting Period
This Form 8-K was filed by Integrity Applications, Inc. (not Glucotrack, Inc.) on June 22, 2021. The registrant is a Delaware corporation with principal executive offices in Ashdod, Israel. The filing reports a corporate governance event rather than financial results.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial statements or performance data.
Material Changes
The material change reported is the appointment of Luis J. Malavé to the Company’s Board of Directors on June 22, 2021. No other material changes to operations or financial status are disclosed in this document.
Management Commentary and Risks
Management highlights Mr. Malavé’s extensive background in the MedTech industry, specifically in diabetes management. His experience includes over 30 years of leadership, serving as President of EOFLOW CO. Ltd., and holding senior executive roles at Insulet Corp., Palyon Medical, Medtronic, and MiniMed. The filing does not disclose specific risks, contingencies, or unusual items related to this appointment.
Investor Verification Checklist
- Verify the registrant name is Integrity Applications, Inc., not Glucotrack, Inc.
- Confirm the effective date of Luis J. Malavé’s board appointment (June 22, 2021).
- Review Mr. Malavé’s prior roles at EOFLOW CO. Ltd. and Insulet Corp. for potential conflicts of interest or strategic alignment.
- Note that no financial data is included in this specific 8-K filing.